AngioDynamics Inc
NASDAQ:ANGO
AngioDynamics Inc
NASDAQ:ANGO
Price:
6.12 USD
1.16%
Market Closed
Updated:
May 13, 2024
AngioDynamics Inc
Cost of Revenue
|
AngioDynamics Inc
Cost of Revenue Peer Comparison
Comparables:
BDX
BSX
SYK
ABT
ISRG
Competitive Cost of Revenue Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Cost of Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
AngioDynamics Inc
NASDAQ:ANGO
|
Cost of Revenue
-$161.5m
|
CAGR 3-Years
-8%
|
CAGR 5-Years
-16%
|
CAGR 10-Years
1%
|
|
|
Becton Dickinson and Co
NYSE:BDX
|
Cost of Revenue
-$11.4B
|
CAGR 3-Years
-6%
|
CAGR 5-Years
-4%
|
CAGR 10-Years
-11%
|
|
|
Boston Scientific Corp
NYSE:BSX
|
Cost of Revenue
-$4.5B
|
CAGR 3-Years
-8%
|
CAGR 5-Years
-9%
|
CAGR 10-Years
-7%
|
|
|
Stryker Corp
NYSE:SYK
|
Cost of Revenue
-$7.5B
|
CAGR 3-Years
-11%
|
CAGR 5-Years
-10%
|
CAGR 10-Years
-10%
|
|
|
Abbott Laboratories
NYSE:ABT
|
Cost of Revenue
-$18B
|
CAGR 3-Years
-4%
|
CAGR 5-Years
-7%
|
CAGR 10-Years
-7%
|
|
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
Cost of Revenue
-$2.5B
|
CAGR 3-Years
-17%
|
CAGR 5-Years
-16%
|
CAGR 10-Years
-14%
|
See Also
What is AngioDynamics Inc's Cost of Revenue?
Cost of Revenue
-161.5m
USD
-161.5m
USD
Based on the financial report for Feb 29, 2024, AngioDynamics Inc's Cost of Revenue amounts to -161.5m USD.
What is AngioDynamics Inc's Cost of Revenue growth rate?
Cost of Revenue CAGR 10Y
1%
1%
Over the last year, the Cost of Revenue growth was -1%. The average annual Cost of Revenue growth rates for AngioDynamics Inc have been -8% over the past three years , -16% over the past five years , and 1% over the past ten years .
You don't have any saved screeners yet
